Foghorn Therapeutics (FHTX) Other Non Operating Income (2019 - 2026)

Foghorn Therapeutics' Other Non Operating Income history runs 8 years deep, the most recent figure standing at -$44000.0 for Q1 2026.

• In Q1 2026, Other Non Operating Income fell 103.17% year-over-year to -$44000.0; the TTM figure through Mar 2026 stood at $1.9 million (down 59.88% YoY), while the FY2025 annual figure was $3.4 million, down 19.26% from the prior year.
• Other Non Operating Income was -$44000.0 for Q1 2026 at Foghorn Therapeutics, down from $502000.0 in the prior quarter.
• In the past five years, Other Non Operating Income ranged from a high of $1.4 million in Q4 2024 to a low of -$44000.0 in Q1 2026.
• Historically, Other Non Operating Income has averaged $758294.1 across 5 years, with a median of $712000.0 in 2023.
• The sharpest annual moves came in 2022 and 2026: Other Non Operating Income soared 152.0% in 2022, then slumped 103.17% in 2026.
• A 5-year view of Other Non Operating Income shows it stood at $624000.0 in 2022, then advanced by 8.65% to $678000.0 in 2023, then surged by 107.37% to $1.4 million in 2024, then slumped by 64.3% to $502000.0 in 2025, then slumped by 108.76% to -$44000.0 in 2026.
• The last three Other Non Operating Income figures came in at -$44000.0 (Q1 2026), $502000.0 (Q4 2025), and $620000.0 (Q3 2025), per Business Quant data.